Converge Bio
Converge Bio56
About
What does Converge Bio do?
Converge Bio is a Generative AI Lab for the Life Sciences that accelerates drug development through AI-powered innovations in discovery, molecule design, and manufacturing. Their platform offers solutions for antibody design and screening, gene expression optimization, and target and biomarker discovery. Converge Bio serves pharmaceutical and biotech companies seeking to create tomorrow's therapies today.
What is Converge Bio's revenue?
StartupHub estimates Converge Bio's annual revenue at $9.0M (range $4.9M to $13.9M, 64% confidence), based on comparable companies in the sector.
What is Converge Bio's valuation?
StartupHub estimates Converge Bio's effective valuation at $21.3M (range $13.8M to $33.0M, 16% confidence), based on comparable companies in the sector.
How much funding has Converge Bio raised?
Converge Bio has raised a total of $6M in funding. The most recent round on record is Seed.
Where is Converge Bio headquartered?
Converge Bio is headquartered in San Francisco, United States.
When was Converge Bio founded?
Converge Bio was founded in 2023.
What industry does Converge Bio operate in?
Converge Bio operates in Life Sciences, Generative AI, Large Language Models (LLMs), Pharmaceutical, Foundation Models, Open Source.
How many employees does Converge Bio have?
Converge Bio has approximately 51 people on record.
No comments yet. Be the first to share your take.